Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Tirzepatide remains more selective as a dual GLP-1/GIP agonist
The compounds don't 'burn fat' directly
Transparency about your medical history during consultation is essential for safety and efficacy
The competitive map is widening, too, as the Novo Nordisk and Eli Lilly duopoly meets oral small molecules, monthly dosing, Eli Lillys retatrutide, a triple hormone receptor agonist, has demonstrated an average weight loss of 28.3% over 80 weeks on the highest dose in Phase 3 trials
Remember that you will most likely need one shot per week and, depending on the amount of weight you desire to lose and the time it will take you, you will most likely need several injections
Always consult your prescriber for further guidance
US$ 27.06
US$ 22.54
US$ 20.93
US$ 21.09
